Overview
Cevimeline is a parasympathomimetic agent that act as an agonist at the muscarinic acetylcholine receptors M1 and M3. It is indicated by the Food and Drug Administration for the treatment of dry mouth associated with Sjögren's syndrome.
Indication
用于治疗各型青光眼。FDA批准用于干燥综合征和放疗引起的口干症。
Associated Conditions
- Dry Mouth
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2013/07/19 | Early Phase 1 | Completed | |||
2013/07/19 | Early Phase 1 | Completed | |||
2012/09/21 | Not Applicable | Completed | |||
2007/04/24 | Phase 4 | Completed | American Academy of Otolaryngology-Head and Neck Surgery Foundation | ||
2003/01/27 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Lupin Pharmaceuticals,Inc. | 43386-999 | ORAL | 30 mg in 1 1 | 1/30/2024 | |
| Advagen Pharma Ltd | 72888-118 | ORAL | 30 mg in 1 1 | 5/3/2023 | |
| Daiichi Sankyo, Inc. | 63395-201 | ORAL | 30 mg in 1 1 | 6/3/2022 | |
| Cosette Pharmaceuticals, Inc. | 0713-0937 | ORAL | 30 mg in 1 1 | 1/5/2023 | |
| Sun Pharmaceutical Industries, Inc. | 63304-479 | ORAL | 30 mg in 1 1 | 7/15/2022 | |
| Novel Laboratories, Inc. | 40032-999 | ORAL | 30 mg in 1 1 | 2/9/2016 | |
| Bryant Ranch Prepack | 63629-9863 | ORAL | 30 mg in 1 1 | 8/3/2018 | |
| Cosette Pharmaceuticals, Inc. | 0713-0883 | ORAL | 30 mg in 1 1 | 9/7/2022 | |
| STAT RX USA LLC | 16590-859 | ORAL | 30 mg in 1 1 | 8/2/2011 | |
| Aurobindo Pharma Limited | 59651-422 | ORAL | 30 mg in 1 1 | 7/2/2022 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.